Therefore, COVID-19 patients with CHD were four times more likely to die than average COVID-19 patients, with an elevated level of proinflammatory cytokines such as IL-6, CRP, and procoagulant factors such as D-Dimer20. The gene discussed is CRP; the disease is COVID-19.